Tex. Gov't Code § 2177.001 · Chapter 2177. TEXAS PHARMACEUTICAL INITIATIVE
DEFINITIONS.
Text — Current through the 89th 2nd Called Legislative Session, 2025
In this chapter:
(1) "Advisory council" means the Texas Pharmaceutical Initiative Advisory Council established under this chapter.
(2) "Board" means the governing board of the initiative.
(3) "Commission" means the Health and Human Services Commission.
(4) "Generic biological product" means a biological product approved pursuant to an application under Section 351(k), Public Health Service Act (42 U.S.C. Section 262(k)).
(5) "Generic drug" means a prescription drug approved pursuant to an application under Section 505(j), Federal Food, Drug, and Cosmetic Act (21 U.S.C. Section 355(j)).
(6) "Initiative" means the Texas Pharmaceutical Initiative established under this chapter.
Notes and commentary — not statutory text
History
Added by Acts 2023, 88th Leg., R.S., Ch. 891 (H.B. 4990), Sec. 1, eff. June 13, 2023.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/GV/htm/GV.2177.htm
- Text hash
- sha256 0b6c5bcb07fe3d6bf0fd5d850c486d38c5561c1d45238841198ac94dd6052eca
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.